Stéphanie Lanoix

Title: Stéphanie Lanoix: Innovator in Pharmaceutical Compounds

Introduction

Stéphanie Lanoix is a notable inventor based in Mansfield, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as ATR kinase inhibitors. His work is crucial for advancing treatments for various medical conditions.

Latest Patents

Stéphanie Lanoix holds one patent titled "Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as ATR kinase inhibitors." This patent discloses compounds and pharmaceutically acceptable salts that may be utilized in treating subjects in need. The compounds are designed to inhibit Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Additionally, the patent includes pharmaceutical compositions containing these compounds and methods for their preparation and use.

Career Highlights

Stéphanie Lanoix is associated with Repare Therapeutics Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that can significantly impact patient care.

Collaborations

Some of his coworkers include Sheldon N Crane and Vouy Linh Truong, who contribute to the collaborative efforts at Repare Therapeutics Inc. Their combined expertise enhances the research and development initiatives within the company.

Conclusion

Stéphanie Lanoix is a prominent figure in the pharmaceutical industry, recognized for his innovative work on ATR kinase inhibitors. His contributions are paving the way for new treatment options that could benefit many patients in need.